An extension study for patients previously enrolled in studies with pelabresib

• Research type

  Research Study

• Full title

  An Open-Label, Multicenter, Extension Study for Patients Previously Enrolled in Studies With Pelabresib

• IRAS ID

  1009918

• Contact name

  Claire Harrison

• Contact email

  claire.harrison@gstt.nhs.uk

• Sponsor organisation

  Constellation Pharmaceuticals, Inc.

• Clinicaltrials.gov Identifier

  NCT06401356

• Research summary

  An extension study for patients previously enrolled in studies with pelabresib

• REC name

  London - Riverside Research Ethics Committee

• REC reference

  24/LO/0289

• Date of REC Opinion

  17 Jun 2024

• REC opinion

  Further Information Favourable Opinion